发明名称 Compositions, methods and uses for poxvirus elements in vaccine constructs against influenza virus subtypes or strains
摘要 Embodiments of the present invention generally disclose methods, compositions and uses for generating and expressing poxvirus constructs. In some embodiments, constructs may contain an influenza virus gene segment. In certain embodiments, methods generally relate to making and using compositions of constructs including, but not limited to, poxvirus vaccine compositions having two or more influenza gene segments. In other embodiments, vaccine compositions are reported of use in a subject.
申请公布号 US9005632(B2) 申请公布日期 2015.04.14
申请号 US201213555026 申请日期 2012.07.20
申请人 Takeda Vaccines, Inc. 发明人 Stinchcomb Dan T.;Osorio Jorge E.;Powell Timothy D.;Jones Jeremy C.;Brewoo Joseph N.
分类号 A61K49/00;A61K39/38;A61K39/295;A61K39/145;A61K39/245;C12Q1/70;C12N15/863;A61K39/12;C07K14/005;A61K39/00 主分类号 A61K49/00
代理机构 Faegre Baker Daniels LLP 代理人 Faegre Baker Daniels LLP
主权项 1. A construct comprising: a modified vaccinia virus construct encoding at least one vaccinia virus secretory signal sequence associated with a first influenza protein, and at least a second influenza protein; wherein the at least one vaccinia virus secretory signal sequence comprises, at least one of a secretory signal sequence of C13L or B8R; wherein the influenza proteins in the construct are capable of inducing an immune response in a subject.
地址 Deerfield IL US
您可能感兴趣的专利